Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A **combination topical skincare regimen** composed of three distinct products: - **benzoyl peroxide**: a topical antimicrobial agent that works by releasing oxygen free radicals, killing Propionibacterium acnes and reducing inflammation for the treatment of acne vulgaris. - **Dermotivin Soft Liquid Cleanser**: a gentle liquid facial cleanser, intended for sensitive or dry skin, typically used to cleanse the skin and remove debris prior to the application of medicated or moisturizing products; specific actives may include mild surfactants, moisturizers, or skin-soothing agents (exact composition depends on local product variant). - **Cetaphil Dermacontrol Moisturizer SPF30**: a broad-spectrum facial moisturizer designed for oily and acne-prone skin, which contains chemical sunscreen agents (avobenzone, octisalate, octocrylene) for UVA/UVB protection, along with ingredients for hydration (glycerin, panthenol, ceramides), oil control (micropearl technology), and soothing (zinc gluconate, allantoin). This regimen aims to **cleanse**, **treat acne**, and **provide oil control, hydration, and sun protection** for sensitive or oily, acne-prone skin[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on benzoyl peroxide + Dermotivin Soft Liquid Cleanser + Cetaphil Dermacontrol Moisturizer SPF30.